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To the editor: Saran et al.1 reported in their recent study that
longer treatment and slower ultrafiltration in hemodialysis
resulted in reduced mortality. However, their study could not
rule out the interference of the awareness of treatment time
(TT). In Japan there was stronger correlation between TT and
urea kinetics (Kt/V) than that in Europe or the US (0.14
versus 0.03 or 0.01). That is presumably because TT in Japan
depends more remarkably on net total filtration volume
whereas TT in Europe and the US depends on Kt/V. Japanese
are sufficiently small for body size achievable target Kt/V
within that of ultrafiltration rate (UFR).
This study concluded that the cardiopulmonary mortality
is less influenced by the effect of longer TT and lower UFR
than that of all-cause mortality. We are concerning if there
were careful considerations for the following points. We
usually prescribe TT to achieve target Kt/V and/or to achieve
target dry weight using safer maximal UFR. Sometimes,
lower maximal UFR is obligatory required because of low
cardiac function and low blood pressure. We wonder if this
report included certain number of such cases. If so, it will
potentially reduce the power of lower UFR to detect
cardiopulmonary risk. Admittedly, in a previous report, low
systolic blood pressure inducing lower maximal UFR
associate with high risk for mortality.2 These aspects are
not clearly discussed in this article.
UFR (ml/h/kg) and Kt/V is full dependent factor of TT,
which is overlooked in this study. It should have been more
confident if the UFR (ml/h/kg) is changed to total ultra-
filtration volume (ml/session/kg) and Kt/V to time limited
Kt/V (e.g. TT 210 min only). TT must be carefully handled in
multivariate analysis about UFR.
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We are grateful to Dr Okamoto et al.1 for providing
insightful comments in response to our published paper
dealing with the issues of treatment time (TT) and
ultrafiltration rate (UFR) in the Dialysis Outcomes and
Practice Patterns Study.2 We wish to respond to the three
main points they make. (I) They speculate that the reason
for the relatively strong correlation observed between TT
and Kt/V in Japan is because TT in Japan is decided based
on total ultrafiltration volume, whereas in Europe and the
US, TT is more dependent on target Kt/V. They also make
the point that it is perhaps easier to achieve target Kt/V in
Japan owing to the relatively smaller body size of the
Japanese patients (we agree with this statement). We have
previously observed in the Dialysis Outcomes and Practice
Patterns Study that interdialytic weight gains are, on
average, relatively higher in Japan.3 It may well be that TT
in Japan is usually at or above 4 h because they target the
ultrafiltration volume over a longer time owing to the
belief that longer TT is useful in the delivery of
hemodialysis, a practice pattern that reflects achievement
of dialysis adequacy by prolonging time (as we discuss in
the paper) rather than other measures such as higher blood
flow rate or utilization of larger dialyzers which are more
likely to be used in the US. (II) It is quite possible that low
UFR is generally applied when patient’s blood pressure is
low predialysis, or for the prevention of intradialytic
hypotension. Even if there is such confounding as Dr
Okinamoto et al. suggest, the results are independent of
the multiple co-morbidities that were adjusted for in our
analyses, and suggest that low UFR may actually be pro-
tective for all-cause mortality. We agree that low UFR may
be more weakly associated with reduced cardiovascular
mortality because of the fact that it is confounded by low
blood pressure, which itself is a predictor of higher
mortality in dialysis patients. However, this hypothesis
would need to be tested formally. (III) We recognized that
both UFR (ml/min/kg) and Kt/V have ‘T’ in them.
However, the Cox proportional hazards models have both
variables simultaneously and TT. Despite potential colli-
nearity, the variables are independently associated with
outcomes. Furthermore, we reported an interaction
between Kt/V and T, such that for any Kt/V a longer time
was independently protective. This interaction directly
addresses the ‘time-limited Kt/V’ issue, which is raised in
the letter. Overall, the points made by Drs Okamoto,
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